Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi‐country observational study

INTRODUCTION: Clinical guidelines recommend extended treatment with dual antiplatelet therapy (DAPT) with ticagrelor 60 mg (twice daily) beyond 12 months in high‐risk patients with a history of myocardial infarction (MI) who have previously tolerated DAPT and are not at heightened bleeding risk. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Lesén, Eva, Hewitt, Christopher, Giannitsis, Evangelos, Hedberg, Jonatan, Jernberg, Tomas, Lambrelli, Dimitra, Maggioni, Aldo P., Simeone, Jason C., Ariza‐Solé, Albert, Storey, Robert F., ten Berg, Jurrien, Bonaca, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Clinical Study Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495086/
https://www.ncbi.nlm.nih.gov/pubmed/34365644
http://dx.doi.org/10.1002/clc.23702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495086/
https://www.ncbi.nlm.nih.gov/pubmed/34365644
http://dx.doi.org/10.1002/clc.23702

Ejemplares similares